SUBCUTANEOUS EPCORITAMAB IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA: SAFETY PROFILE AND ANTI‐TUMOR ACTIVITY

Author:

Hutchings M1,Mous R2,Clausen M. R3,Johnson P4,Linton K5,Lewis D. J6,Chamuleau M. E.D7,Balari A. S8,Cunningham D9,DeMarco D10,Chen K.‐M10,Elliott B10,Lugtenburg P11

Affiliation:

1. Rigshospitalet, Copenhagen University Hospital Department of Hematology Copenhagen Denmark

2. On behalf of the Lunenburg Lymphoma Phase I/II Consortium‐HOVON/LLPC Universitair Medisch Centrum Utrecht Department of Hematology Utrecht Netherlands

3. Vejle Hospital Department of Hematology Veile Denmark

4. Cancer Research UK, Cancer Services University of Southampton Department of Hematology Southampton UK

5. Christie Hospital NHS Foundation Trust Division of Cancer Services Manchester UK

6. Plymouth University Medical School Department of Hematology Plymouth UK

7. On behalf of the Lunenburg Lymphoma Phase I/II Consortium‐HOVON/LLPC VU University Medical Center Department of Hematology Amsterdam Netherlands

8. Institut Català d'Oncologia‐Hospital Duran i Reynals, Hospitalet del Llobregat Department of Hematology Barcelona Spain

9. The Royal Marsden NHS Foundation Trust Department of Hematology Sutton UK

10. Genmab Clinical Research and Development Princeton, New Jersey USA

11. On behalf of the Lunenburg Lymphoma Phase I/II Consortium‐HOVON/LLPC Erasmus MC Cancer Institute Department of Hematology Rotterdam Netherlands

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3